ANXA5 and neoplasm: Indeed, intra-tumoural release of AnxA5 from intravenously injected nanoparticles effectively blocked phagocytosis of apoptotic cells, which then triggered a strong cytotoxic T cell response and immunological memory that led to complete tumour regression in 50% of mice with orthotopic breast tumours [267].